⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LIXT News
Lixte Biotechnology Holdings, Inc. Common Stock
IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
globenewswire.com
LIXT
LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
globenewswire.com
LIXT
Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct Offering
globenewswire.com
LIXT
Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules
globenewswire.com
LIXT
LIXTE's Strategy Comes Into Focus: Building an Oncology Platform Around Complementary Modalities
accessnewswire.com
LIXT
LIXTE Levels Up From PP2A Innovation to Multi-Modal Oncology
accessnewswire.com
LIXT
LIXTE Steps Into a Key Role in the Rise of Treatment Amplifiers
accessnewswire.com
LIXT
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
globenewswire.com
LIXT
LIXTE's Bold Blueprint to Rewire Cancer's Master Switch and Redefine Its Own Future (NASDAQ: LIXT)
accessnewswire.com
LIXT
LIXTE Bio's Transformational Summer Marked by Leadership Updates, Scientific Progress, and Digital Treasury Strategy (NASDAQ:LIXT)
accessnewswire.com
LIXT